Inflammation, synovial angiogenesis and chondroid apoptosis in the evolution of type II collagen-induced arthritis.
Using the murine model of type II collagen-induced arthritis (CIA), we studied its evolution over time by histopathological, immunohistochemical and clinical evaluations. The first clinical symptoms appeared 28 days post-inoculation (dpi), with bovine type II collagen, with an average arthritic index of 1.00 +/- 0.48 corresponding to erythema of the articulation. The disease progressed, and by 70 dpi showed an average arthritic index of 3.83 +/- 0.27 corresponding to edema and maximum deformation, with ankylosis. Computed morphometry demonstrated that, in comparison to controls, the induction of CIA, produces a significant and increasing accumulation of inflammatory cells, fibrosis (p < 0.0001) and cartilage destruction (p = 0.0029). Likewise, the area of von Willebrand factor (vWF) immunostaining, as an indicator of endothelial proliferation, increased significantly from 28 dpi (p < 0.0001), in CIA mice compared to controls. However, the effective synovial vascularization, calculated as the synovial vascular bed area index, significantly increased by 42 dpi (p = 0.0014). This indicates that the activation and proliferation of endothelium becomes significant before an effective vascularization area is formed. The apoptosis index was also an earlier indicator of cartilage damage, becoming significant from 28 dpi in comparison to controls (p < 0.0001). Finally, it was observed that the increase in the arthritic index showed a strong correlation with the increase in both angiogenesis (r = 0.95; p = 0.0021) and apoptosis (r = 0.90; p = 0.0015). In conclusion, a robust correlation between synovial membrane inflammation, angiogenesis and chondrocyte apoptosis, with respect to the increase in the clinical severity of CIA, has been demonstrated by a quantitative computer-assisted immunomorphometric analysis.
González
Carlos
C
Departamento de Patología Animal, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Santiago, Chile.
Abello
Paula
P
Cepeda
Raquel
R
Salazar
Lorena
L
Aravena
Octavio
O
Pesce
Barbara
B
Catalán
Diego
D
Aguillón
Juan C
JC
D000704:Analysis of Variance; D000818:Animals; D017209:Apoptosis / Q000276:immunology; D001169:Arthritis, Experimental / Q000503:physiopathology*; D002417:Cattle; D019902:Chondrocytes / Q000166:cytology / Q000276:immunology; D004195:Disease Models, Animal; D018450:Disease Progression; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D007596:Joints / Q000098:blood supply / Q000473:pathology; D051379:Mice; D008811:Mice, Inbred DBA; D009389:Neovascularization, Pathologic / Q000473:pathology / Q000503:physiopathology*; D012720:Severity of Illness Index; D013583:Synovial Membrane / Q000473:pathology / Q000503:physiopathology*; D013585:Synovitis / Q000473:pathology / Q000503:physiopathology*; D014841:von Willebrand Factor / Q000032:analysis